Long-wavelength iodide-sensitive fluorescent indicators for measurement of functional CFTR expression in cells

1999 ◽  
Vol 277 (5) ◽  
pp. C1008-C1018 ◽  
Author(s):  
Sujatha Jayaraman ◽  
Leah Teitler ◽  
Bohdan Skalski ◽  
A. S. Verkman

Limitations of available indicators [such as 6-methoxy- N-(3-sulfopropyl)quinolinium (SPQ)] for measurement of intracellular Cl− are their relatively dim fluorescence and need for ultraviolet excitation. A series of long-wavelength polar fluorophores was screened to identify compounds with Cl− and/or I− sensitivity, bright fluorescence, low toxicity, uniform loading of cytoplasm with minimal leakage, and chemical stability in cells. The best compound found was 7-(β-d-ribofuranosylamino)-pyrido[2,1-h]-pteridin-11-ium-5-olate (LZQ). LZQ is brightly fluorescent with excitation and emission maxima at 400–470 and 490–560 nm, molar extinction 11,100 M−1 ⋅ cm−1(424 nm), and quantum yield 0.53. LZQ fluorescence is quenched by I− by a collisional mechanism (Stern-Volmer constant 60 M−1) and is not affected by other halides, nitrate, cations, or pH changes (pH 5–8). After LZQ loading into cytoplasm by hypotonic shock or overnight incubation, LZQ remained trapped in cells (leakage <3%/h). LZQ stained cytoplasm uniformly, remained chemically inert, did not bind to cytoplasmic components, and was photobleached by <1% during 1 h of continuous illumination. Cytoplasmic LZQ fluorescence was quenched selectively by I− (50% quenching at 38 mM I−). LZQ was used to measure forskolin-stimulated I−/Cl−and I−/[Formula: see text]exchange in cystic fibrosis transmembrane conductance regulator (CFTR)-expressing cell lines by fluorescence microscopy and microplate reader instrumentation using 96-well plates. The substantially improved optical and cellular properties of LZQ over existing indicators should permit the quantitative analysis of CFTR function in gene delivery trials and high-throughput screening of compounds for correction of the cystic fibrosis phenotype.

2005 ◽  
Vol 73 (10) ◽  
pp. 6822-6830 ◽  
Author(s):  
Nina Reiniger ◽  
Jeffrey K. Ichikawa ◽  
Gerald B. Pier

ABSTRACT Chronic lung infection by Pseudomonas aeruginosa causes significant morbidity in cystic fibrosis patients initiated by the failure of innate immune responses. We used microarray analysis and real-time PCR to detect transcriptional changes associated with cytokine production in isogenic bronchial epithelial cell lines with either wild-type (WT) or mutant cystic fibrosis transmembrane conductance regulator (CFTR) in response to P. aeruginosa infection. The transcription of four NF-κB-regulated cytokine genes was maximal in the presence of WT CFTR: the interleukin-8 (IL-8), IL-6, CXCL1, and intracellular adhesion molecule 1 (ICAM-1) genes. Analysis of protein expression in two cell lines paired for wild-type and mutant CFTR with three P. aeruginosa strains showed IL-6 and IL-8 expressions were consistently enhanced by the presence of WT CFTR in both cell lines with all three strains of P. aeruginosa, although some strains gave small IL-8 increases in cells with mutant CFTR. CXCL1 production showed consistent enhancement in cells with WT CFTR using all three bacterial strains in one cell line, whereas in the other cell line, CXCL1 showed a significant increase in cells with either WT or mutant CFTR. ICAM-1 was unchanged at the protein level in one of the cell lines but did show mild enhancement with WT CFTR in the other cell pair. Inhibitions of NF-κB prior to infection indicated differing degrees of dependence on NF-κB for production of the cytokines, contingent on the cell line. Cytokine effectors of innate immunity to P. aeruginosa were found to be positively influenced by the presence of WT CFTR, indicating a role in resistance to P. aeruginosa infection.


2000 ◽  
Vol 279 (1) ◽  
pp. C62-C71 ◽  
Author(s):  
Valerie J. Wheat ◽  
Holli Shumaker ◽  
Charles Burnham ◽  
Gary E. Shull ◽  
James R. Yankaskas ◽  
...  

Thickening of airway mucus and lung dysfunction in cystic fibrosis (CF) results, at least in part, from abnormal secretion of Cl− and HCO3 −across the tracheal epithelium. The mechanism of the defect in HCO3 − secretion is ill defined; however, a lack of apical Cl−/HCO3 − exchange may exist in CF. To test this hypothesis, we examined the expression of Cl−/HCO3 − exchangers in tracheal epithelial cells exhibiting physiological features prototypical of cystic fibrosis [CFT-1 cells, lacking a functional cystic fibrosis transmembrane conductance regulator (CFTR)] or normal trachea (CFT-1 cells transfected with functional wild-type CFTR, termed CFT-WT). Cells were grown on coverslips and were loaded with the pH-sensitive dye 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein, and intracellular pH was monitored. Cl−/HCO3 −exchange activity increased by ∼300% in cells transfected with functional CFTR, with activities increasing from 0.034 pH/min in CFT-1 cells to 0.11 in CFT-WT cells ( P < 0.001, n = 8). This activity was significantly inhibited by DIDS. The mRNA expression of the ubiquitous basolateral AE-2 Cl−/HCO3 − exchanger remained unchanged. However, mRNA encoding DRA, recently shown to be a Cl−/HCO3 − exchanger (Melvin JE, Park K, Richardson L, Schultheis PJ, and Shull GE. J Biol Chem 274: 22855–22861, 1999.) was abundantly expressed in cells expressing functional CFTR but not in cells that lacked CFTR or that expressed mutant CFTR. In conclusion, CFTR induces the mRNA expression of “downregulated in adenoma” (DRA) and, as a result, upregulates the apical Cl−/HCO3 − exchanger activity in tracheal cells. We propose that the tracheal HCO3 −secretion defect in patients with CF is partly due to the downregulation of the apical Cl−/HCO3 −exchange activity mediated by DRA.


1991 ◽  
Vol 19 (19) ◽  
pp. 5417-5423 ◽  
Author(s):  
Kunihiko Yoshimura ◽  
Hidenori Nakamura ◽  
Bruce C. Trapnell ◽  
Chin-Shyan Chu ◽  
Wilfeuwnd Dakemans ◽  
...  

2017 ◽  
Vol 22 (3) ◽  
pp. 315-324 ◽  
Author(s):  
Feng Liang ◽  
Haibo Shang ◽  
Nikole J. Jordan ◽  
Eric Wong ◽  
Dayna Mercadante ◽  
...  

Cystic fibrosis (CF) is a hereditary disease caused by mutations in the gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR). A large number of nearly 2000 reported mutations, including the premature termination codon (PTC) mutations, urgently require new and personalized medicines. We have developed cell-based assays for readthrough modulators of CFTR PTC mutations (or nonsense mutation suppressors), based on the trafficking and surface expression of CFTR. Approximately 85,000 compounds have been screened for two PTC mutations (Y122X and W1282X). The hit rates at the threshold of 50% greater than vehicle response are 2% and 1.4% for CFTR Y122X and CFTR W1282X, respectively. The overlap of the two hit sets at this stringent hit threshold is relatively small. Only ~28% of the hits from the W1282X screen were also hits in the Y122X screen. The overlap increases to ~50% if compounds are included that in the second screen achieve only a less stringent hit criterion, that is, horseradish peroxidase (HRP) activity greater than three standard deviations above the mean of the vehicle. Our data suggest that personalization may not need to address individual genotypes, but that patients with different CFTR PTC mutations could benefit from the same medicines.


PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e48059 ◽  
Author(s):  
Angel G. Valdivieso ◽  
Mariángeles Clauzure ◽  
María C. Marín ◽  
Guillermo L. Taminelli ◽  
María M. Massip Copiz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document